Commodore Capital as of June 30, 2021
Portfolio Holdings for Commodore Capital
Commodore Capital holds 29 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Aclaris Therapeutics (ACRS) | 10.2 | $29M | 1.7M | 17.56 | |
Satsuma Pharmaceuticals Ord | 7.6 | $22M | 3.1M | 7.05 | |
Celcuity (CELC) | 7.3 | $21M | 871k | 24.00 | |
C4 Therapeutics Com Stk (CCCC) | 6.3 | $18M | 481k | 37.84 | |
Cymabay Therapeutics | 5.4 | $15M | 3.5M | 4.36 | |
Constellation Pharmceticls I | 5.2 | $15M | 441k | 33.80 | |
Cytokinetics Com New (CYTK) | 4.9 | $14M | 704k | 19.79 | |
Kura Oncology (KURA) | 4.5 | $13M | 622k | 20.85 | |
Cogent Biosciences (COGT) | 3.9 | $11M | 1.4M | 8.11 | |
Iveric Bio | 3.8 | $11M | 1.7M | 6.31 | |
Celldex Therapeutics Com New (CLDX) | 3.8 | $11M | 323k | 33.44 | |
Macrogenics (MGNX) | 3.7 | $11M | 394k | 26.86 | |
Vistagen Therapeutics Com New | 3.7 | $11M | 3.3M | 3.15 | |
Protagonist Therapeutics (PTGX) | 3.3 | $9.5M | 211k | 44.88 | |
Essa Pharma Com New (EPIX) | 2.8 | $8.1M | 282k | 28.57 | |
Kronos Bio (KRON) | 2.5 | $7.2M | 299k | 23.95 | |
Genocea Biosciences Com New (GNCAQ) | 2.4 | $6.9M | 2.9M | 2.34 | |
Mereo Biopharma Group Ads (MREO) | 2.3 | $6.5M | 2.1M | 3.17 | |
Dyne Therapeutics (DYN) | 2.2 | $6.4M | 305k | 21.04 | |
Xenon Pharmaceuticals (XENE) | 2.1 | $6.1M | 326k | 18.62 | |
Mersana Therapeutics (MRSN) | 2.0 | $5.8M | 429k | 13.58 | |
Kalvista Pharmaceuticals (KALV) | 1.9 | $5.4M | 227k | 23.96 | |
Pmv Pharmaceuticals (PMVP) | 1.5 | $4.3M | 125k | 34.16 | |
Inventiva Sa Ads (IVA) | 1.2 | $3.6M | 263k | 13.63 | |
Seres Therapeutics (MCRB) | 1.2 | $3.5M | 146k | 23.85 | |
Catabasis Pharmaceuticals In Com New | 1.2 | $3.4M | 1.6M | 2.11 | |
Miragen Therapeutics (VRDN) | 1.2 | $3.4M | 186k | 18.29 | |
Silverback Therapeutics (SPRY) | 1.0 | $3.0M | 97k | 30.89 | |
Bcls Acquisition Corp Com Cl A | 0.9 | $2.6M | 250k | 10.53 |